drugset

drugset / Trial / NCT07143929

To Observe the CD7-targeted CAR-T Therapy in the Treatment of r/r PTCL

NCT07143929 ↗

Phase 1 Recruiting 18 enrolled Peking University People's Hospital

NaSingle-groupOpen-labelTreatment

Summary

To observe the efficacy and safety of CD7-targeted chimeric antigen receptor T cells in the treatment of refractory or relapsed PTCL.

Timeline

Start: 2025-08-18
Primary completion: 2026-07-31
Completion: 2027-12-31

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	CAR-T	Cell therapy	—	—

Indications